- Home
- TPST vs SEGG Comparison
TPST vs SEGG Comparison
Compare TPST & SEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPST | SEGG |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 11.6M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TPST | SEGG |
|---|---|---|
| Price | $0.53 | $1.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 306.6K | 32.7K |
| Earning Date | 11-04-2026 | 10-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 70.56 |
| EPS | N/A | ★ N/A |
| Revenue | $295,000.00 | ★ $6,779,057.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.52 | $0.42 |
| 52 Week High | $11.13 | $4.95 |
Technical Indicators
Market Signals| Indicator | TPST | SEGG |
|---|---|---|
| Relative Strength Index (RSI) | 27.88 | 24.72 |
| Support Level | N/A | $0.90 |
| Resistance Level | $1.24 | $1.59 |
| Average True Range (ATR) | 0.05 | 0.23 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 2.69 | 3.62 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.
About SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a world-wide sports, entertainment and gaming company operating at the intersection of digital content, fan engagement and regulated gaming. It is building an integrated ecosystem designed to connect fans to the games, events and experiences it care about in compliant, technology-enabled environments. It is operated as a single-reporting unit focused on its lottery and gaming platform, and its organizational structure, internal reporting systems, and resource allocation processes were aligned accordingly. The company owns and operates three premium domain brands: Sports.com, Concerts.com, and Lottery.com representing the company's three operating focuses: Sports, Entertainment, and Gaming.